Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel in Primary Generalized Tonic-Clonic Seizures
NCT01393743Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2011
- Primary completion
- May 2014
- Modality
- Classical Binding Small Molecules
01
Overview
A Phase 3 trial of perampanel in generalized tonic-clonic seizure (GTCS), sponsored by Eisai Co., Ltd.. Started Sep 2011; status: completed.
02
Drugs
perampanel
03
Conditions
generalized tonic-clonic seizure (GTCS)
Beyond the preview
Go deeper on NCT01393743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01393743.